市場調査レポート

商品コード

急性膵炎の市場規模・予測、世界・地域シェア、動向、成長機会分析レポート範囲：製品別、原因別、エンドユーザー別、地域別

Acute Pancreatitis Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offerings, Causes, End User, and Geography

出版日: 2023年09月08日 | 発行: The Insight Partners

| ページ情報: 英文 196 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 712,757円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,057円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,339,357円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.65円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

急性膵炎の市場規模は、2022年の56億4,977万米ドルから2030年には88億2,737万米ドルに達すると予測され、2022年から2030年までのCAGRは5.7％を記録すると推定されます。

膵臓は、血糖値を調節するホルモンであるインスリンを産生します。膵炎は膵臓のインスリン産生細胞を傷つけ、急性膵炎に罹患した患者に糖尿病を引き起こします。急性膵炎に罹患している人は、一般の人に比べて糖尿病のリスクが2倍高いです。世界保健機関（WHO）アメリカ糖尿病学会は、急性膵炎後の糖尿病の発症を膵外分泌性糖尿病（膵原性糖尿病）に分類しています。膵原性糖尿病は、膵外分泌障害と関連することが多くなってきています。糖尿病の後遺症は急性膵炎の重症度範囲にわたって観察され、他の臨床合併症を伴うこともあります。

2022年に発表されたEuropean Review for Medical and Pharmacological Sciencesによれば、欧米の糖尿病患者集団における膵原性糖尿病の有病率は5～10％であり、急性膵炎が80％を引き起こすのに対し、慢性膵炎が20％を占める。2021年にNational Library of Medicineに掲載された論文によると、急性膵炎患者の～23％が退院後3年以内に糖尿病を発症する可能性が高いです。さらに、2020年にJournal of Gastroenterology誌に掲載された論文によると、急性膵炎後、退院後6ヶ月、12ヶ月、18ヶ月、24ヶ月の時点で、それぞれ～3%、7%、9%、11%の患者が糖尿病を発症します。MDPIに掲載された論文によると、2023年には急性膵炎患者の～40％が糖尿病予備軍や糖尿病に罹患しており、2型糖尿病患者よりも死亡や再入院のリスクが高いです。さらに、成人患者の～60.2％が急性膵炎後に糖尿病を発症し、小児の9％が急性再発性膵炎後または慢性膵炎後に糖尿病を発症し、このリスクは成人期になるにつれて増加します。調査者は、重症と軽症の急性膵炎を比較したメタアナリシスにおいて、重症急性膵炎後の糖尿病発症率（～39％）が軽症急性膵炎（14％）よりも高いことを指摘しています。

中国の調査研究によると、高トリグリセリド血症（HTG）がアルコールを抜いて急性膵炎の第2位の原因になっています。患者の約29％が再発性急性膵炎（RAP）を経験し、そのうちの44.6％が高トリグリセリド血症を病因としていました。2023年6月にBiomed Central誌に発表された論文では、HTGは急性膵炎の重症度と再発の重要な独立した危険因子であると述べられています。このように、急性膵炎に罹患または回復した患者における糖尿病の発生率の増加は、急性膵炎市場の成長に寄与しています。

急性膵炎市場は製品とエンドユーザーに区分されます。提供物に基づき、急性膵炎市場は投薬、診断、その他に区分されます。2022年には、診断セグメントが最大のシェアを占めています。さらに、その他セグメントは予測期間（2022-2030年）に最速のCAGRを記録すると予測されています。診断セグメントの急性膵炎市場は、さらに血液検査、CTスキャン、便検査、超音波検査、MRI、尿検査に区分されます。原因に基づき、急性膵炎市場は胆石、アルコール中毒、遺伝性疾患、感染症、その他に分類されます。2022年には、胆石セグメントが市場で最大のシェアを占めました。同セグメントは予測期間中（2022～2030年）に最も高いCAGR率を記録すると予測されています。エンドユーザーに基づき、急性膵炎市場は病院、診断研究所、外来手術センター、その他に分類されます。2022年には、病院セグメントが市場で最大のシェアを占めました。診断検査室セグメントの急性膵炎市場は、予測期間（2022-2030年）にCAGR 6.4％で成長すると予測されます。

地域別に見ると、市場は北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分されます。北米のフリージオンは急性膵炎市場で最大の市場シェアを占めています。北米の急性膵炎市場は、胆石症例数の増加やアルコールの過剰摂取による疾病負担の増加により成長が見込まれています。また、ヘルスケア施設の技術進歩も北米の急性膵炎市場に利益をもたらしています。米国では、アルコール摂取の広範な習慣と胆石症例の急増により、急性膵炎症例数が増加しています。APACは2022年から2030年にかけて最も高い成長率を記録すると予想されています。APACの市場開拓は、膵炎症例の増加、膵炎の治療法を開発する研究者、国民の意識を高めるための政府の取り組みなどの要因によるものです。また、アルコール関連膵炎の症例も同地域の市場成長を後押ししています。

経済協力開発機構（OECD）、米国疾病予防管理センター（CDC）、欧州連合（EU）、米国国立衛生研究所（NIH）は、急性膵炎市場に関する報告書を作成する際に参照した一次情報および二次情報の一部です。

主な市場促進要因
- 急性膵炎による膵がん患者の増加
- 急性膵炎後の糖尿病罹患率の上昇
主な市場抑制要因
- 膵炎および膵がん治療の副作用
主な市場機会
- 急性膵炎に関する研究開発活動および啓発プログラムの増加
今後の動向
- 特定の急性膵炎治療の進歩
インパクト分析

第6章急性膵炎市場：世界市場分析

急性膵炎市場の収益、2022年～2030年

第7章急性膵炎の世界市場急性膵炎の世界市場-収益と2030年までの予測-製品別

急性膵炎市場の収益シェア（提供品別）、2022年・2030年（%）
薬物療法
診断薬
その他

第8章急性膵炎の世界市場-2030年までの収益と予測-原因別

急性膵炎市場の2022年・2030年原因別売上高シェア（%）
胆石症
アルコール中毒
遺伝性疾患
感染症
その他

第9章急性膵炎の世界市場：エンドユーザー別収益と2030年までの予測

急性膵炎市場のエンドユーザー別収益シェア（2022年・2030年）
病院
診断研究所
外来手術センター
その他

第10章急性膵炎市場：地域別分析

北米
- メキシコ
欧州
- その他欧州
アジア太平洋
- その他アジア太平洋地域
中東・アフリカ
- その他中東とアフリカ
中南米
- その他中南米

第11章急性膵炎市場-業界情勢

急性膵炎市場における成長戦略
無機的成長戦略
有機的成長戦略

第12章企業プロファイル

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Actim Oy
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第13章付録

図表

List Of Tables

Table 1. Acute Pancreatitis Market Segmentation
Table 2. Global Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. US Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. US Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. US Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. US Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. US Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. UK Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. UK Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. UK Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. UK Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 38. Germany Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 39. France Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 40. France Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 41. France Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 42. France Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 43. France Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 44. Italy Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 48. Italy Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 49. Spain Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 50. Spain Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 51. Spain Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 52. Spain Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 53. Spain Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 54. Nordic Region Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 55. Nordic Region Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 56. Nordic Region Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 57. Nordic Region Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 58. Nordic Region Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. Netherlands Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 60. Netherlands Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 61. Netherlands Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 62. Netherlands Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 63. Netherlands Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 74. China Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 75. China Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 76. China Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 77. China Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 78. China Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 79. Japan Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 84. India Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 85. India Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 86. India Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 87. India Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 88. India Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 89. Australia Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 90. Australia Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 91. Australia Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 94. South Korea Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 95. South Korea Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 96. South Korea Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 97. South Korea Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 99. Rest of Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 100. Rest of Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 101. Rest of Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 102. Rest of Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 103. Rest of Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 104. Middle East & Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 105. Middle East & Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 106. Middle East & Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 107. Middle East & Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 108. Middle East & Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 109. Saudi Arabia Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 110. Saudi Arabia Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 111. Saudi Arabia Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 112. Saudi Arabia Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 113. Saudi Arabia Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 114. UAE Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 115. UAE Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 116. UAE Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 117. UAE Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 118. UAE Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 119. South Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 120. South Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 121. South Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 122. South Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 123. South Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 124. Rest of Middle East & Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 125. Rest of Middle East & Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 126. Rest of Middle East & Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 127. Rest of Middle East & Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 128. Rest of Middle East & Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 129. South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 130. South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 131. South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 132. South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 133. South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 134. Brazil Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 135. Brazil Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 136. Brazil Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 137. Brazil Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 138. Brazil Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 139. Argentina Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 140. Argentina Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 141. Argentina Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 142. Argentina Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 143. Argentina Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 144. Rest of South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 145. Rest of South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 146. Rest of South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 147. Rest of South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 148. Rest of South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 149. Recent Inorganic Growth Strategies in the Acute Pancreatitis Market
Table 150. Recent Organic Growth Strategies in the Acute Pancreatitis Market
Table 151. Glossary of Terms, Acute Pancreatitis Market

List Of Figures

Figure 1. Acute Pancreatitis Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Acute Pancreatitis Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Acute Pancreatitis Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 7. Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 8. Medications: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Diagnosis: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 12. Gallstones: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alcoholism: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Genetic Disorders: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infections: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 18. Hospitals: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Diagnostic Laboratories: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. North America: Acute Pancreatitis Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. North America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 25. US Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Canada Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Mexico Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Europe Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 29. Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 31. UK Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Germany Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. France Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Italy Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Spain Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Nordic Region Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Netherlands Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 56. South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in the Acute Pancreatitis Market

Product Code: TIPRE00017674

The acute pancreatitis market size is expected to reach US$ 8,827.37 million by 2030 from US$ 5,649.77 million in 2022; it is estimated to record a CAGR of 5.7% from 2022 to 2030.

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. The World Health Organization (WHO) American Diabetes Association has classified the development of diabetes after acute pancreatitis as exocrine pancreatic diabetes (pancreatogenic diabetes). Pancreatogenic diabetes is increasingly being linked to exocrine disorders of the pancreas. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes, and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis.

A Chinese research study suggests that hypertriglyceridemia (HTG) has outpaced alcohol to become the second leading cause of acute pancreatitis. Approximately 29% of patients experience repeated episodes that result in recurrent acute pancreatitis (RAP) and 44.6% of these patients had HTG as an etiological condition. In an article published in Biomed Central in June 2023, HTG has been stated as a significant independent risk factor for the severity and recurrence of acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the acute pancreatitis market.

The acute pancreatitis market is segments into product and end user. Based on offerings, the Acute Pancreatitis Market is segmented into medication, diagnosis, and others. In 2022, the diagnosis segment held the largest share of the market. Moreover, the others segment is expected to record the fastest CAGR during the forecast period (2022-2030). The acute pancreatitis market for the diagnosis segment is further segmented into blood tests, CT scans, stool tests, ultrasound, MRI, and urine tests. Based on causes, the acute pancreatitis market is classified into gallstones, alcoholism, genetic disorders, infection, and others. In 2022, the gallstones segment held the largest share of the market. The same segment is expected to record the highest CAGR rate during the forecast period (2022-2030). Based on end user, the acute pancreatitis market is classified into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market. The acute pancreatitis market for the diagnostic laboratories segment is estimated to grow at a CAGR of 6.4% during the forecast period (2022-2030).

Based on geopgraphy, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North America fregion held the largest market share of the acute pancreatitis market. The acute pancreatitis market in North America is expected to grow due to the increasing burden of the disease with an increase in the number of gallstone cases and excessive consumption of alcohol. Also, technological advancements in healthcare facilities are benefitting the acute pancreatitis market in North America. The US reports an increasingly large number of acute pancreatitis cases due to a wide-scale practice of alcohol consumption and an upsurge in the cases of gallstones. APAC is expected to register the highest growth rate during 2022-2030. The market growth in APAC is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuels the growth of the market in the region.

The Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), European Union, and National Institutes of Health (NIH) are a few key primary and secondary sources referred to while preparing the report on the acute pancreatitis market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the acute pancreatitis market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global acute pancreatitis market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the acute pancreatitis market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Acute Pancreatitis Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Acute Pancreatitis Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. Acute Pancreatitis Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Global Market Analysis

6.1 Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Global Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Global Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Acute Pancreatitis Market - Geographical Analysis

10.1 North America Acute Pancreatitis Market, Revenue and Forecast To 2030
- 10.1.1 Overview
- 10.1.2 North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.3 North America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
  - 10.1.3.1 North America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
  - 10.1.3.2 North America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.4 North America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.5 North America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.1.5.1 North America Acute Pancreatitis Market, by Country
  - 10.1.5.2 US
    - 10.1.5.2.1 Overview
    - 10.1.5.2.2 US Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.5.2.3 US: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.2.3.1 US: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.2.3.2 US: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.2.4 US: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.1.5.2.5 US: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.1.5.3 Canada
    - 10.1.5.3.1 Overview
    - 10.1.5.3.2 Canada Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.5.3.3 Canada: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.3.3.1 Canada: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.3.3.2 Canada: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.3.4 Canada: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.1.5.3.5 Canada: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.1.5.4 Mexico
    - 10.1.5.4.1 Overview
    - 10.1.5.4.2 Mexico Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.5.4.3 Mexico: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.4.3.1 Mexico: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.4.3.2 Mexico: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.1.5.4.4 Mexico: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.1.5.4.5 Mexico: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
10.2 Europe Acute Pancreatitis Market, Revenue and Forecast to 2030
- 10.2.1 Overview
- 10.2.2 Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.2.3 Europe: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
  - 10.2.3.1 Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
  - 10.2.3.2 Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.2.4 Europe: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.2.5 Europe: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.1 Europe Acute Pancreatitis Market, by Country
  - 10.2.5.2 UK
    - 10.2.5.2.1 Overview
    - 10.2.5.2.2 UK Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.2.3 UK: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.2.3.1 UK: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.2.3.2 UK: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.2.4 UK: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.2.5 UK: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.3 Germany
    - 10.2.5.3.1 Overview
    - 10.2.5.3.2 Germany Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.3.3 Germany: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.3.3.1 Germany: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.3.3.2 Germany: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.3.4 Germany: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.3.5 Germany: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.4 France
    - 10.2.5.4.1 Overview
    - 10.2.5.4.2 France Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.4.3 France: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.4.3.1 France: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.4.3.2 France: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.4.4 France: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.4.5 France: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.5 Italy
    - 10.2.5.5.1 Overview
    - 10.2.5.5.2 Italy Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.5.3 Italy: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.5.3.1 Italy: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.5.3.2 Italy: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.5.4 Italy: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.5.5 Italy: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.6 Spain
    - 10.2.5.6.1 Overview
    - 10.2.5.6.2 Spain Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.6.3 Spain: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.6.3.1 Spain: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.6.3.2 Spain: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.6.4 Spain: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.6.5 Spain: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.7 Nordic Region
    - 10.2.5.7.1 Overview
    - 10.2.5.7.2 Nordic Region Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.7.3 Nordic Region: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.7.3.1 Nordic Region: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.7.3.2 Nordic Region: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.7.4 Nordic Region: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.7.5 Nordic Region: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.8 Netherlands
    - 10.2.5.8.1 Overview
    - 10.2.5.8.2 Netherlands Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.8.3 Netherlands: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.8.3.1 Netherlands: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.8.3.2 Netherlands: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.8.4 Netherlands: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.8.5 Netherlands: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.2.5.9 Rest of Europe
    - 10.2.5.9.1 Overview
    - 10.2.5.9.2 Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.5.9.3 Rest of Europe: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.9.3.1 Rest of Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.9.3.2 Rest of Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.2.5.9.4 Rest of Europe: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.2.5.9.5 Rest of Europe: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
10.3 Asia Pacific Acute Pancreatitis Market, Revenue and Forecast to 2030
- 10.3.1 Overview
- 10.3.2 Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.3.3 Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
  - 10.3.3.1 Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
  - 10.3.3.2 Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.3.4 Asia Pacific: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.3.5 Asia Pacific: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.1 Asia Pacific Acute Pancreatitis Market, by Country
  - 10.3.5.2 China
    - 10.3.5.2.1 Overview
    - 10.3.5.2.2 China Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.2.3 China: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.2.3.1 China: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.2.3.2 China: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.2.4 China: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.2.5 China: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.3 Japan
    - 10.3.5.3.1 Overview
    - 10.3.5.3.2 Japan Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.3.3 Japan: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.3.3.1 Japan: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.3.3.2 Japan: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.3.4 Japan: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.3.5 Japan: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.4 India
    - 10.3.5.4.1 Overview
    - 10.3.5.4.2 India Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.4.3 India: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.4.3.1 India: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.4.3.2 India: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.4.4 India: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.4.5 India: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.5 Australia
    - 10.3.5.5.1 Overview
    - 10.3.5.5.2 Australia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.5.3 Australia: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.5.3.1 Australia: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.5.3.2 Australia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.5.4 Australia: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.5.5 Australia: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.6 South Korea
    - 10.3.5.6.1 Overview
    - 10.3.5.6.2 South Korea Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.6.3 South Korea: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.6.3.1 South Korea: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.6.3.2 South Korea: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.6.4 South Korea: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.6.5 South Korea: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.3.5.7 Rest of Asia Pacific
    - 10.3.5.7.1 Overview
    - 10.3.5.7.2 Rest of Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.5.7.3 Rest of Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.7.3.1 Rest of Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.7.3.2 Rest of Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.3.5.7.4 Rest of Asia Pacific: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.3.5.7.5 Rest of Asia Pacific: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
10.4 Middle East & Africa Acute Pancreatitis Market, Revenue and Forecast to 2030
- 10.4.1 Overview
- 10.4.2 Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.4.3 Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
  - 10.4.3.1 Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
  - 10.4.3.2 Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.4.4 Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.4.5 Middle East & Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.4.5.1 Middle East & Africa Acute Pancreatitis Market, by Country
  - 10.4.5.2 Saudi Arabia
    - 10.4.5.2.1 Overview
    - 10.4.5.2.2 Saudi Arabia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.5.2.3 Saudi Arabia: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.2.3.1 Saudi Arabia: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.2.3.2 Saudi Arabia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.2.4 Saudi Arabia: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.4.5.2.5 Saudi Arabia: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.4.5.3 UAE
    - 10.4.5.3.1 Overview
    - 10.4.5.3.2 UAE Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.5.3.3 UAE: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.3.3.1 UAE: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.3.3.2 UAE: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.3.4 UAE: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.4.5.3.5 UAE: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.4.5.4 South Africa
    - 10.4.5.4.1 Overview
    - 10.4.5.4.2 South Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.5.4.3 South Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.4.3.1 South Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.4.3.2 South Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.4.4 South Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.4.5.4.5 South Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.4.5.5 Rest of Middle East & Africa
    - 10.4.5.5.1 Overview
    - 10.4.5.5.2 Rest of Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.5.5.3 Rest of Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.5.3.1 Rest of Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.5.3.2 Rest of Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.4.5.5.4 Rest of Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.4.5.5.5 Rest of Middle East & Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
10.5 South & Central America Acute Pancreatitis Market, Revenue and Forecast to 2030
- 10.5.1 Overview
- 10.5.2 South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.5.3 South & Central America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
  - 10.5.3.1 South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
  - 10.5.3.2 South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.5.4 South & Central America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.5.5 South & Central America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.5.5.1 South & Central America Acute Pancreatitis Market, by Country
  - 10.5.5.2 Brazil
    - 10.5.5.2.1 Overview
    - 10.5.5.2.2 Brazil Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.5.2.3 Brazil: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.2.3.1 Brazil: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.2.3.2 Brazil: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.2.4 Brazil: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.5.5.2.5 Brazil: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.5.5.3 Argentina
    - 10.5.5.3.1 Overview
    - 10.5.5.3.2 Argentina Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.5.3.3 Argentina: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.3.3.1 Argentina: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.3.3.2 Argentina: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.3.4 Argentina: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.5.5.3.5 Argentina: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  - 10.5.5.4 Rest of South & Central America
    - 10.5.5.4.1 Overview
    - 10.5.5.4.2 Rest of South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.5.4.3 Rest of South & Central America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.4.3.1 Rest of South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.4.3.2 Rest of South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    - 10.5.5.4.4 Rest of South & Central America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    - 10.5.5.4.5 Rest of South & Central America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)

11. Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Actim Oy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Fresenius Kabi AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

急性膵炎の市場規模・予測、世界・地域シェア、動向、成長機会分析レポート範囲：製品別、原因別、エンドユーザー別、地域別

Acute Pancreatitis Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offerings, Causes, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章急性膵炎市場情勢

第5章急性膵炎市場-主要産業力学

第6章急性膵炎市場：世界市場分析

第7章急性膵炎の世界市場急性膵炎の世界市場-収益と2030年までの予測-製品別

第8章急性膵炎の世界市場-2030年までの収益と予測-原因別

第9章急性膵炎の世界市場：エンドユーザー別収益と2030年までの予測

第10章急性膵炎市場：地域別分析

第11章急性膵炎市場-業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Acute Pancreatitis Market Landscape

5. Acute Pancreatitis Market - Key Industry Dynamics

6. Acute Pancreatitis Market - Global Market Analysis

7. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

8. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

9. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

10. Acute Pancreatitis Market - Geographical Analysis

11. Acute Pancreatitis Market-Industry Landscape

12. Company Profiles

13. Appendix

急性膵炎の市場規模・予測、世界・地域シェア、動向、成長機会分析レポート範囲：製品別、原因別、エンドユーザー別、地域別

Acute Pancreatitis Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offerings, Causes, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 急性膵炎市場情勢

第5章 急性膵炎市場-主要産業力学

第6章 急性膵炎市場：世界市場分析

第7章 急性膵炎の世界市場急性膵炎の世界市場-収益と2030年までの予測-製品別

第8章 急性膵炎の世界市場-2030年までの収益と予測-原因別

第9章 急性膵炎の世界市場：エンドユーザー別収益と2030年までの予測

第10章 急性膵炎市場：地域別分析

第11章 急性膵炎市場-業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Acute Pancreatitis Market Landscape

5. Acute Pancreatitis Market - Key Industry Dynamics

6. Acute Pancreatitis Market - Global Market Analysis

7. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

8. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

9. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

10. Acute Pancreatitis Market - Geographical Analysis

11. Acute Pancreatitis Market-Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章急性膵炎市場情勢

第5章急性膵炎市場-主要産業力学

第6章急性膵炎市場：世界市場分析

第7章急性膵炎の世界市場急性膵炎の世界市場-収益と2030年までの予測-製品別

第8章急性膵炎の世界市場-2030年までの収益と予測-原因別

第9章急性膵炎の世界市場：エンドユーザー別収益と2030年までの予測

第10章急性膵炎市場：地域別分析

第11章急性膵炎市場-業界情勢

第12章企業プロファイル

第13章付録